摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氨基-4-氰基吡啶 | 78790-79-1

中文名称
3-氨基-4-氰基吡啶
中文别名
3-氨基异烟腈
英文名称
3-aminoisonicotinonitrile
英文别名
3-amino-4-cyano-pyridine;3-Amino-4-cyanopyridine;3-aminopyridine-4-carbonitrile
3-氨基-4-氰基吡啶化学式
CAS
78790-79-1
化学式
C6H5N3
mdl
——
分子量
119.126
InChiKey
PEZNQSQPDQLHPN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    135-138℃
  • 沸点:
    332.9±27.0 °C(Predicted)
  • 密度:
    1.23±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    62.7
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险等级:
    6.1
  • 危险品标志:
    Xn
  • 危险类别码:
    R22
  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P280,P301+P310,P311
  • 危险性描述:
    H302

SDS

SDS:f5f1885d12e724750c56658b5dd3ddf5
查看
Material Safety Data Sheet

Section 1. Identification of the substance
3-Amino-4-cyanopyridine
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H301: Toxic if swallowed
H311: Toxic in contact with skin
H319: Causes serious eye irritation
P280: Wear protective gloves/protective clothing/eye protection/face protection
IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician
P301+P310:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P361: Remove/Take off immediately all contaminated clothing
P405: Store locked up

Section 3. Composition/information on ingredients.
3-Amino-4-cyanopyridine
Ingredient name:
CAS number: 78790-79-1

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H5N3
Molecular weight: 119.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN3439 Class: 6.1 Packing group: III
Proper shipping name: NITRILES, TOXIC, SOLID, N.O.S. (3-Amino-4-cyanopyridine)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-氨基-4-氰基吡啶 在 bis-triphenylphosphine-palladium(II) chloride 、 N-溴代丁二酰亚胺(NBS)N-碘代丁二酰亚胺copper(l) iodide1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 sodium formate 、 potassium acetate 、 palladium diacetate 、 caesium carbonate三乙胺N,N-二异丙基乙胺联硼酸频那醇酯 作用下, 以 四氢呋喃1,4-二氧六环甲醇二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 25.25h, 生成 N-(4-(7-cyano-3-(4-methylthiazol-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[3,2-b]pyridin-2-yl)pyridin-2-yl)acetamide
    参考文献:
    名称:
    TGF BETA R ANTAGONISTS
    摘要:
    这项发明通常涉及调节TGFβR-1和TGFβR-2活性的化合物,包含这些化合物的药物组合物以及利用该发明的化合物治疗增殖性疾病和失调凋亡疾病(如癌症)的方法。
    公开号:
    US20160176871A1
  • 作为产物:
    描述:
    3-叠氮基-4-氰基吡啶 在 palladium on activated charcoal 、 氢气 作用下, 以 乙醇 为溶剂, 以78%的产率得到3-氨基-4-氰基吡啶
    参考文献:
    名称:
    Huprine衍生物作为人乙酰胆碱酯酶抑制剂的合成及其构效关系
    摘要:
    已经合成了新系列的Huprine(12-氨基-6,7,10,11-四氢-7,11-甲氨基环辛[ b ]喹啉)衍生物,并报道了它们对重组人乙酰胆碱酯酶(rh-AChE)的抑制活性。我们合成了两个系列的胡派林类似物;在第一个中,喹啉部分的苯环已被不同的杂环或吸电子或给电子的取代苯基取代。设计第二个是为了评估在位置12处修饰的影响,在位置12处已将不同的短连接子引入到Huprine X,Y骨架上。所有这些分子都是由乙基或甲基双环[3.3.1] non-6-en-3-one通过Friedländer反应(涉及选定的邻位)制备的。-氨基氰基芳族化合物。也已经报道了基于这些Huprines的两种异二聚体的合成。已获得比最活跃的Huprines X和Y具有中等活性至相同范围的活性,最有效的类似物的活性比亲本Huprines X和Y低约三倍。拓扑​​结构数据是从分子对接和活性变化推断得出的不同接头之间的连
    DOI:
    10.1016/j.bmc.2009.05.005
点击查看最新优质反应信息

文献信息

  • Construction of Bicyclic 1,2,3-Triazine <i>N</i>-Oxides from Aminocyanides
    作者:Yuji Liu、Xiujuan Qi、Wenquan Zhang、Ping Yin、Ziwu Cai、Qinghua Zhang
    DOI:10.1021/acs.orglett.0c03952
    日期:2021.2.5
    Using a facile and cost-effective method, nine bicyclic 1,2,3-triazine 2-oxides were synthesized from o-aminocyanide substrates through an unusual nitration cyclization. The reaction mechanism was studied experimentally and theoretically. Moreover, nine 1,2,3-triazine 3-oxides were also obtained in good yields.
    使用一种简便且经济高效的方法,通过不寻常的硝化环化反应,从邻化物底物合成了九种双环1,2,3-三嗪2-氧化物。对反应机理进行了实验和理论研究。此外,还以良好的产率获得了九种1,2,3-三嗪3-氧化物。
  • Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or
    申请人:Pfizer Inc.
    公开号:US05202440A1
    公开(公告)日:1993-04-13
    Compounds selected from the group consisting of 9-amino-4-oxa-1,2,3,4-tetrahydro-acridine, 9-amino-2-oxa-1,2,3,4-tetrahydro-acridine, 9-amino-8-fluoro-4-oxa-1,2,3,4-tetrahydro-acridine, 9-amino-4-oxa-1,2,3,4,5,6,7,8-octahydro-acridine or a pharmaceutical acceptable salt thereof are useful treating Alzheimer's disease.
    从由9-基-4-氧杂-1,2,3,4-四氢吖啶、9-基-2-氧杂-1,2,3,4-四氢吖啶、9-基-8--4-氧杂-1,2,3,4-四氢吖啶、9-基-4-氧杂-1,2,3,4,5,6,7,8-八氢吖啶或其药物可接受盐组成的组中选出的化合物,用于治疗阿尔茨海默病是有用的。
  • One-Pot Synthesis of 4-Quinolone via Iron-Catalyzed Oxidative Coupling of Alcohol and Methyl Arene
    作者:Seok Beom Lee、Yoonkyung Jang、Jiwon Ahn、Simin Chun、Dong-Chan Oh、Suckchang Hong
    DOI:10.1021/acs.orglett.0c03011
    日期:2020.11.6
    Herein, we describe the iron(III)-catalyzed oxidative coupling of alcohol/methyl arene with 2-amino phenyl ketone to synthesize 4-quinolone. Alcohols and methyl arenes are oxidized to the aldehyde in the presence of an iron catalyst and di-tert-butyl peroxide, followed by a tandem process, condensation with amine/Mannich-type cyclization/oxidation, to complete the 4-quinolone ring. This method tolerates
    在本文中,我们描述了/(III)催化的醇/甲基芳烃与2-基苯基酮的氧化偶联,以合成4-喹诺酮。在催化剂和二叔丁基过氧化物的存在下,将醇和甲基芳烃氧化为醛,然后进行串联反应,与胺/曼尼希型环化/氧化反应缩合,完成4-喹诺酮环。该方法可耐受各种官能团,并提供了直接从功能化程度较低的底物合成4-喹诺酮的方法。
  • Discovery and Structure–Activity Relationships of <i>N</i> ‐Aryl 6‐Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors
    作者:Nicolas Boutard、Arkadiusz Białas、Aleksandra Sabiniarz、Paweł Guzik、Katarzyna Banaszak、Artur Biela、Marcin Bień、Anna Buda、Barbara Bugaj、Ewelina Cieluch、Anna Cierpich、Łukasz Dudek、Hans‐Michael Eggenweiler、Joanna Fogt、Monika Gaik、Andrzej Gondela、Krzysztof Jakubiec、Mirek Jurzak、Agata Kitlińska、Piotr Kowalczyk、Maciej Kujawa、Katarzyna Kwiecińska、Marcin Leś、Ralph Lindemann、Monika Maciuszek、Maciej Mikulski、Paulina Niedziejko、Alicja Obara、Henryk Pawlik、Tomasz Rzymski、Magdalena Sieprawska‐Lupa、Marta Sowińska、Joanna Szeremeta‐Spisak、Agata Stachowicz、Mateusz M. Tomczyk、Katarzyna Wiklik、Łukasz Włoszczak、Sylwia Ziemiańska、Adrian Zarębski、Krzysztof Brzózka、Mateusz Nowak、Charles‐Henry Fabritius
    DOI:10.1002/cmdc.201800569
    日期:2019.1.8
    is the ubiquitous and hypoxia‐induced isoform of PFK‐2, are reported. X‐ray crystallography and docking were instrumental in the design and optimisation of a series of Naryl 6‐aminoquinoxalines. The most potent representative, N‐(4‐methanesulfonylpyridin‐3‐yl)‐8‐(3‐methyl‐1‐benzothiophen‐5‐yl)quinoxalin‐6amine, displayed an IC50 of 14 nm for the target and an IC50 of 0.49 μm for fructose‐2,6‐biphosphate
    癌细胞的能量和生物质生产在很大程度上被有氧糖酵解所支持,这就是所谓的Warburg效应。该过程受关键酶的调节,其中磷酸果糖激酶PFK-2通过产生果糖-2,6-二磷酸而起重要作用。磷酸果糖激酶PFK-1执行的最有效的糖酵解限速步骤激活剂。本文介绍了6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酯酶3(PFKFB3)的新型抑制剂的合成,生物学评估以及其结构与活性之间的关系,PFKFB3是一种普遍存在且由低氧引起的PFK-2亚型,被报道。X射线晶体学和对接有助于设计和优化一系列N-芳基6-氨基喹喔啉。最有力的代表,N-(4-甲磺酰基吡啶-3-基)-8-(3-甲基-1-苯并噻吩-5-基)喹喔啉-6-胺,目标物的IC 50为14 n m,0.4的IC 50为0.49μm m为人类结肠癌HCT116细胞中果糖2,6-二磷酸的产生。这项工作为PFKFB3抑制剂领域的发展提供了新的机会。
  • Substrate Profiling of the Cobalt Nitrile Hydratase from Rhodococcus rhodochrous ATCC BAA 870
    作者:Adelaide R. Mashweu、Varsha P. Chhiba-Govindjee、Moira L. Bode、Dean Brady
    DOI:10.3390/molecules25010238
    日期:——
    cross-coupling reactions and imidazo[1,2-a]pyridines prepared by the Groebke–Blackburn–Bienaymé multicomponent reaction. The enzyme active site was moderately accommodating, accepting almost all of the small aromatic nitriles, the diarylpyridines and most of the bi-aryl compounds and Morita–Baylis–Hillman products but not the Groebke–Blackburn–Bienaymé products. Nitrile conversion was influenced by steric
    对来自玫瑰色红球菌 ATCC BAA 870 的腈水合酶的芳香底物特征进行了评估,并针对多种含腈化合物 (>60)。为了确定这种酶的底物限度,评估了大小从小 (90 Da) 到大 (325 Da) 的化合物。较大的化合物包括通过 Suzuki 偶联反应制备的具有双芳基轴的化合物、Morita-BAylis-Hillman 加合物、通过 Buchwald-Hartwig 交叉偶联反应制备的杂原子连接的二芳基吡啶和通过制备的咪唑并 [1,2-a] 吡啶Groebke-Blackburn-Bienaymé 多组分反应。酶活性位点适中,接受几乎所有的小芳香腈,二芳基吡啶和大多数双芳基化合物和 Morita-BAylis-Hillman 产品,但不是 Groebke-Blackburn-Bienaymé 产品。腈的转化率受基周围的空间位阻、芳环上给电子基团(例如甲氧基)的存在以及化合物的整体大小的影响。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-